Medtronic, a healthcare technology company based in Ireland, plans to separate its diabetes business into a standalone, publicly traded company by the end of 2026.  The company announced the move May ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...